CryoPort, Inc. (CYRX) financial statements (2021 and earlier)

Company profile

Business Address 112 WESTWOOD PLACE, SUITE 350
BRENTWOOD, TN 37027
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
3/31/2016
3/31/2015
3/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments93944715310
Cash and cash equivalents37473715310
Short-term investments564710    
Receivables31742111
Inventory, net of allowances, customer advances and progress billings11000000
Inventory11000000
Other current assets     00
Other undisclosed current assets121110  
Total current assets:1471035217421
Noncurrent Assets
Finance lease, right-of-use asset00
Operating lease, right-of-use asset144
Property, plant and equipment301243100
Intangible assets, net (including goodwill)3591600000
Goodwill14511     
Intangible assets, net (excluding goodwill)214500000
Other noncurrent assets1      
Other undisclosed noncurrent assets1 000 0
Total noncurrent assets:4053353201
TOTAL ASSETS:5521365720632
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:25221111
Employee-related liabilities7211110
Other undisclosed accounts payable and accrued liabilities17100100
Deferred revenue00
Debt010  12
Due to related parties    01 
Other undisclosed current liabilities10211112
Total current liabilities:35532234
Noncurrent Liabilities
Long-term debt and lease obligation129415    
Long-term debt, excluding current maturities116 15    
Finance lease, liability00
Capital lease obligations0    
Operating lease, liability124
Liabilities, other than long-term debt600010 
Deferred revenue and credits0   
Deferred rent credit  0
Deferred income tax liabilities60
Due to related parties    10 
Other liabilities0      
Total noncurrent liabilities:135415010 
Total liabilities:17010182334
Stockholders' equity
Stockholders' equity attributable to parent, including:38312639183(0)(2)
Common stock0000000
Additional paid in capital5662861801491169784
Accumulated other comprehensive income (loss)5(0)0    
Accumulated deficit(192)(159)(141)(131)(113)(98)(86)
Other undisclosed stockholders' equity attributable to parent3    0 
Total stockholders' equity:38312639183(0)(2)
TOTAL LIABILITIES AND EQUITY:5521365720632

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
3/31/2016
3/31/2015
3/31/2014
Revenues79342012643
Revenue, net12643
Cost of revenue(42)(17)(9)(6)(4)(3)(2)
Gross profit:3617106210
Operating expenses(66)(35)(19)(14)(11)(7)(6)
Operating loss:(30)(18)(9)(8)(9)(6)(5)
Nonoperating income (expense)(3)1(1)(0)(0)1(0)
Investment income, nonoperating1(0) (0) (0)(0)
Debt instrument, convertible, beneficial conversion feature     1 
Other nonoperating income (expense)(1)100(0)(0)(0)
Interest and debt expense(3)(1)(0)(0)(1)(1)(14)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes3000 (1)0
Loss from continuing operations before income taxes:(33)(18)(10)(8)(10)(7)(20)
Income tax expense (benefit)0(0)(0)(0)(0)(0)(0)
Net loss attributable to parent:(33)(18)(10)(8)(10)(7)(20)
Preferred stock dividends and other adjustments    (5)(5) 
Other undisclosed net loss available to common stockholders, basic(42)      
Net loss available to common stockholders, diluted:(75)(18)(10)(8)(15)(12)(20)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
3/31/2016
3/31/2015
3/31/2014
Net loss:(33)(18)(10)(8)(10)(7)(20)
Comprehensive loss:(33)(18)(10)(8)(10)(7)(20)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent5(0)0    
Comprehensive loss, net of tax, attributable to parent:(27)(18)(10)(8)(10)(7)(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: